The investigational protocols of the Pediatric Oncology Group (POG) form the foundation for the clinical and laboratory research programs in pediatric oncology at the University of Mississippi Medical Center (UMC) in Jackson, Mississippi. The cooperative research efforts of the POG member institutions are yielding important new information concerning the biology and therapy of most types of pediatric malignancies. The UMC and its POG affiliate institution, Keesler AFB Medical Center, are the only centers in Mississippi providing comprehensive care for children with cancer. The UMC's participation in the POG incorporates the multidisciplinary input of pediatric medical oncology, pediatric surgery, pediatric pathology, radiotherapy, radiology. cytogenetics, and immunology both locally and in the scientific and administrative activities of the group. The UMC principal investigator has recently served as POG New ALL (Acute Lymphocytic Leukemia) Committee chairman and is continuing to participate in all of the core and planning committee functions of the New ALL Committee. The POG protocols for children with newly diagnosed ALL include the classification protocols which explore the laboratory subclassification of ALL and route patients-to the specific treatment protocols for T, B, and non-T, non-B ALL. POG protocols specially designed for T-ALL and B-ALL, respectively, are improving the outcome of these poor risk groups of childhood ALL. The UMC is providing the current chair for the POG Cytogenetics Committee. The UMC is coordinating the POG 8035 (ALinC 13) and POG 8600 (ALinC 14) classification studies for patients with newly diagnosed ALL and will coordinate the POG 9000 (ALinC 15) classification study. The UMC is also coordinating the POG 8036 (ALinC 13) New ALL treatment study.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
Application #
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Mississippi Medical Center
Schools of Medicine
United States
Zip Code
Wacker, Pierre; Land, Vita J; Camitta, Bruce M et al. (2007) Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology Group Study. J Pediatr Hematol Oncol 29:627-32
Whitehead, V M; Shuster, J J; Vuchich, M J et al. (2005) Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Leukemia 19:533-6
Shamberger, Robert C; LaQuaglia, Michael P; Gebhardt, Mark C et al. (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563-7; discussion 567-8
Goorin, Allen M; Harris, Michael B; Bernstein, Mark et al. (2002) Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. J Clin Oncol 20:426-33
Winter, S S; Sweatman, J; Shuster, J J et al. (2002) Bone marrow stroma-supported culture of T-lineage acute lymphoblastic leukemic cells predicts treatment outcome in children: a Pediatric Oncology Group study. Leukemia 16:1121-6
Mahoney Jr, D H; Cohen, M E; Friedman, H S et al. (2000) Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study. Neuro Oncol 2:213-20
Pullen, J; Shuster, J J; Link, M et al. (1999) Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. Leukemia 13:1696-707
Borowitz, M J; Rubnitz, J; Nash, M et al. (1998) Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study. Leukemia 12:1764-70
Camitta, B M; Pullen, J; Murphy, S (1997) Biology and treatment of acute lymphocytic leukemia in children. Semin Oncol 24:83-91
Martin, P L; Look, A T; Schnell, S et al. (1996) Comparison of fluorescence in situ hybridization, cytogenetic analysis, and DNA index analysis to detect chromosomes 4 and 10 aneuploidy in pediatric acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Pediatr Hematol Oncol 18:113-21

Showing the most recent 10 out of 23 publications